Institute for Follicular Lymphoma Innovation Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2
- Investments
-
7
- Portfolio
-
6
- Exits
-
1
Institute for Follicular Lymphoma Innovation General Information
Company Description
Founded in 2022, Institute for Follicular Lymphoma Innovation is a not-for-profit venture capital firm based in Los Angeles, California. The firm seeks to invest in non-profit and for-profit organizations operating in the research and treatment of Follicular Lymphoma (FL).
Business Details
Website
www.i-fli.orgYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 1440 Bridgegate Drive
- Diamond Bar
- Los Angeles, CA 91765
- United States
Institute for Follicular Lymphoma Innovation Investments (7)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| NanoCell Therapeutics | 16-Jun-2025 | Seed Round | Drug Discovery | Generating Revenue | ||
| Enterome | 12-Jun-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| LTZ Therapeutics | 23-Apr-2025 | Drug Discovery | Generating Revenue | |||
| Verismo Therapeutics | 08-Jan-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| PeproMene Bio | 19-Dec-2024 | Drug Discovery | Generating Revenue | |||
| Innate Pharma | 06-Dec-2024 | PIPE | Drug Discovery | Generating Revenue | ||
| Araris | 04-Oct-2022 | Early Stage VC | Drug Discovery | Generating Revenue |
Institute for Follicular Lymphoma Innovation Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Araris | 31-Mar-2025 |
Institute for Follicular Lymphoma Innovation Investments by Industry, Year, and Region
Institute for Follicular Lymphoma Innovation Co-Investors (22)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Lilly USA | 1 |
|
|
||
| Qatar Investment Authority |
|
|
|||
| Qiming Venture Partners |
|
|
|||
| Schroders Capital |
|
|
|||
| Seventure |
|
|
Institute for Follicular Lymphoma Innovation FAQs
-
What is Institute for Follicular Lymphoma Innovation?
Founded in 2022, Institute for Follicular Lymphoma Innovation is a not-for-profit venture capital firm based in Los Angeles, California.
-
When was Institute for Follicular Lymphoma Innovation founded?
Institute for Follicular Lymphoma Innovation was founded in 2022.
-
Where is Institute for Follicular Lymphoma Innovation headquartered?
Institute for Follicular Lymphoma Innovation is headquartered in Los Angeles, CA.
-
How many investments has Institute for Follicular Lymphoma Innovation made?
Institute for Follicular Lymphoma Innovation has made 7 investments.
-
What has Institute for Follicular Lymphoma Innovation invested in?
Institute for Follicular Lymphoma Innovation has made numerous investments in companies like NanoCell Therapeutics, Enterome, and LTZ Therapeutics within the Drug Discovery industry.
-
What has Institute for Follicular Lymphoma Innovation invested in recently?
Institute for Follicular Lymphoma Innovation's latest investment was on 16-Jun-2025 in NanoCell Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process